Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2013, Article ID 151028, 8 pages
http://dx.doi.org/10.1155/2013/151028
Review Article

Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold

1Faculty of Medicine, University Witten/Herdecke, Alfred-Herrhausen-Straße 50, 58448 Witten, Germany
2Department of Research and Development, Institute for Neuropathic Pain, Spoorlaan 2a, 3735 MV Bosch en Duin, The Netherlands
3Division of Human Nutrition (Bode 62), Wageningen University, P.O. Box 8129, 6700 EV Wageningen, The Netherlands

Received 3 April 2013; Revised 9 June 2013; Accepted 10 June 2013

Academic Editor: Juan Carlos Kaski

Copyright © 2013 J. M. Keppel Hesselink et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. F. Coburn and L. V. Moore, “The prophylactic use of sulfanilamide in streptococcal respiratory infections, with especial reference to rheumatic fever,” Journal of Clinical Investigation, vol. 18, pp. 147–155, 1939. View at Publisher · View at Google Scholar
  2. A. Coburn, “The concept of egg yolk as a dietary inhibitor to rheumatic susceptibility,” The Lancet, vol. 275, no. 7129, pp. 867–870, 1960. View at Google Scholar · View at Scopus
  3. A. F. Coburn, C. E. Graham, and J. Haninger, “The effect of egg yolk in diets on anaphylactic arthritis (passive Arthus phenomenon) in the guinea pig,” The Journal of Experimental Medicine, vol. 100, pp. 425–435, 1954. View at Google Scholar
  4. D. A. Long and A. J. P. Martin, “Factor in arachis oil depressing sensitivity to tuberculin in B.C.G.-infected guineapigs,” The Lancet, vol. 267, no. 6921, pp. 464–466, 1956. View at Google Scholar · View at Scopus
  5. O. H. Ganley and H. J. Robinson, “Antianaphylactic and antiserotonin activity of a compound obtained from egg yolk, peanut oil, and soybean lecithin,” Journal of Allergy, vol. 30, no. 5, pp. 415–419, 1959. View at Google Scholar · View at Scopus
  6. F. A. Kuehl Jr., T. A. Jacob, O. H. Ganley, R. E. Ormond, and M. A. P. Meisinger, “The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent,” Journal of the American Chemical Society, vol. 79, no. 20, pp. 5577–5578, 1957. View at Google Scholar · View at Scopus
  7. G. H. Stollerman, “Alvin F. Coburn, 1899–1975,” Journal of Infectious Diseases, vol. 133, no. 5, p. 595, 1976. View at Google Scholar · View at Scopus
  8. O. H. Ganley, O. E. Graessle, and H. J. Robinson, “Anti-inflammatory activity of compounds obtained from egg yolk, peanut oil, and soybean lecithin,” The Journal of Laboratory and Clinical Medicine, vol. 51, no. 5, pp. 709–714, 1958. View at Google Scholar · View at Scopus
  9. N. R. Bachur, K. Masek, K. L. Melmon, and S. Udenffiend, “Fatty acid amides of ethanolamine in mammalian tissues,” The Journal of Biological Chemistry, vol. 240, pp. 1019–1024, 1965. View at Google Scholar · View at Scopus
  10. F. Benvenuti, F. Lattanzi, A. de Gori, and P. Tarli, “Activity of some derivatives of palmitoylethanolamide on carragenine-induced edema in the rat paw,” Bollettino Della Societa Italiana di Biologia Sperimentale, vol. 44, no. 9, pp. 809–813, 1968. View at Google Scholar · View at Scopus
  11. F. Perlík, H. Rasková, and J. Elis, “Anti-inflammatory properties of N(2-hydroxyethyl) palmitamide,” Acta Physiologica Academiae Scientiarum Hungaricae, vol. 39, no. 4, pp. 395–400, 1971. View at Google Scholar · View at Scopus
  12. F. Perlik, J. Krejčí, J. Elis, J. Pekárek, and J. Švejcar, “The effect of N-(2-hydroxyethyl)-palmitamide on delayed hypersensitivity in guinea-pig,” Experientia, vol. 29, no. 1, pp. 67–68, 1973. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Masek, F. Perlik, J. Klima, and R. Kahlich, “Prophylactic efficacy of N 2 hydroxyethyl palmitamide (Impulsin) in acute respiratory tract infections,” European Journal of Clinical Pharmacology, vol. 7, no. 6, pp. 415–419, 1974. View at Google Scholar · View at Scopus
  14. R. Kahlich, J. Klima, F. Cihla et al., “Studies on prophylactic efficacy of N-2-hydroxyethyl palmitamide (Impulsin) in acute respiratory infections. Serologically controlled field trials,” Journal of Hygiene Epidemiology Microbiology and Immunology, vol. 23, no. 1, pp. 11–24, 1979. View at Google Scholar · View at Scopus
  15. V. Plesnik, M. Havrlantova, J. Jancova, J. Januska, and O. Macková, “Impulsin in the prevention of acute respiratory diseases in school children,” Ceskoslovenská Pediatrie, vol. 32, pp. 365–369, 1977. View at Google Scholar
  16. F. Massa, G. Marsicano, H. Hermana et al., “The endogenous cannabinoid system protects against colonic inflammation,” Journal of Clinical Investigation, vol. 113, no. 8, pp. 1202–1209, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. G. D'Argenio, S. Petrosino, C. Gianfrani et al., “Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats,” Journal of Molecular Medicine, vol. 85, no. 5, pp. 523–530, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Sancho, M. A. Calzado, V. di Marzo, G. Appendino, and E. Muñoz, “Anandamide inhibits nuclear factor-κB activation through a cannabinoid receptor-independent pathway,” Molecular Pharmacology, vol. 63, no. 2, pp. 429–438, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Aloe, A. Leon, and R. Levi-Montalcini, “A proposed autacoid mechanism controlling mastocyte behaviour,” Agents and Actions, vol. 39, pp. C145–C147, 1993. View at Google Scholar · View at Scopus
  20. J. M. Keppel Hesselink, “Professor Rita Levi-Montalcini on Nerve Growth Factor, mast cells and palmitoylethanolamide, an endogenous anti-inflammatory and analgesic compound,” Pain and Relief, vol. 2, article 1, 2013. View at Publisher · View at Google Scholar
  21. R. Levi-Montalcini, S. D. Skaper, R. dal Toso, L. Petrelli, and A. Leon, “Nerve growth factor: from neurotrophin to neurokine,” Trends in Neurosciences, vol. 19, no. 11, pp. 514–520, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. I. A. Khasabova, Y. Xiong, L. G. Coicou, D. Piomelli, and V. Seybold, “Peroxisome proliferator-activated receptor alpha mediates acute effects of palmitoylethanolamide on sensory neurons,” The Journal of Neuroscience, vol. 32, pp. 12735–12743, 2012. View at Google Scholar
  23. J. LoVerme, G. la Rana, R. Russo, A. Calignano, and D. Piomelli, “The search for the palmitoylethanolamide receptor,” Life Sciences, vol. 77, no. 14, pp. 1685–1698, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Costa, F. Comelli, I. Bettoni, M. Colleoni, and G. Giagnoni, “The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPARγ receptors and neurotrophic factors,” Pain, vol. 139, no. 3, pp. 541–550, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Godlewski, L. Offertáler, J. A. Wagner, and G. Kunos, “Receptors for acylethanolamides-GPR55 and GPR119,” Prostaglandins and Other Lipid Mediators, vol. 89, no. 3-4, pp. 105–111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. H. S. Hansen and T. A. Diep, “N-acylethanolamines, anandamide and food intake,” Biochemical Pharmacology, vol. 78, no. 6, pp. 553–560, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. H. S. Hansen, “Effect of diet on tissue levels of palmitoylethanolamide,” CNS & Neurological Disorders, vol. 12, no. 1, pp. 17–25, 2013. View at Google Scholar
  28. K. Tsuboi, N. Ikematsu, T. Uyama, D. G. Deutsch, A. Tokumura, and N. Ueda, “Biosynthetic pathways of bioactive N-acylethanolamines in brain,” CNS & Neurological Disorders, vol. 12, no. 1, pp. 7–16, 2013. View at Google Scholar
  29. M. G. J. Balvers, K. C. M. Verhoeckx, S. Bijlsma et al., “Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues,” Metabolomics, vol. 8, no. 6, pp. 1130–1147, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. G. Balvers, K. C. Verhoeckx, J. Meijerink, H. M. Wortelboer, and R. F. Witkamp, “Measurement of palmitoylethanolamide and other N-acylethanolamines during physiological and pathological conditions,” CNS & Neurological Disorders, vol. 12, no. 1, pp. 23–33, 2013. View at Google Scholar
  31. E. Esposito and S. Cuzzocrea, “Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries,” CNS & Neurological Disorders, vol. 12, no. 1, pp. 55–61, 2013. View at Google Scholar
  32. M. M. Joosten, M. G. J. Balvers, K. C. M. Verhoeckx, H. F. J. Hendriks, and R. F. Witkamp, “Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women,” Nutrition and Metabolism, vol. 7, article 49, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Bisogno, “Endogenous cannabinoids: structure and metabolism,” Journal of Neuroendocrinology, vol. 20, no. 1, pp. 1–9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Q. Wei, T. S. Mikkelsen, M. K. McKinney, E. S. Lander, and B. F. Cravatt, “A second fatty acid amide hydrolase with variable distribution among placental mammals,” Journal of Biological Chemistry, vol. 281, no. 48, pp. 36569–36578, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. J. F. Bermejo-Martin, R. Ortiz de Lejarazu, T. Pumarola et al., “Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza,” Critical Care, vol. 13, p. R201, 2009. View at Google Scholar
  36. T. H. Mogensen and S. R. Paludan, “Molecular pathways in virus-induced cytokine production,” Microbiology and Molecular Biology Reviews, vol. 65, pp. 131–150, 2001. View at Publisher · View at Google Scholar
  37. I. Meunier, C. Embury-Hyatt, S. Stebner et al., “Virulence differences of closely related pandemic 2009 H1N1 isolates correlate with increased inflammatory responses in ferrets,” Virology, vol. 422, no. 1, pp. 125–131, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. M. B. Rothberg and S. D. Haessler, “Complications of seasonal and pandemic influenza,” Critical Care Medicine, vol. 38, supplement 4, pp. e91–e97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Kaiser, R. S. Fritz, S. E. Straus, L. Gubareva, and F. G. Hayden, “Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses,” Journal of Medical Virology, vol. 64, no. 3, pp. 262–268, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. M. L. Heltzer, S. E. Coffin, K. Maurer et al., “Immune dysregulation in severe influenza,” Journal of Leukocyte Biology, vol. 85, no. 6, pp. 1036–1043, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Yu, X. Zhang, B. Zhao et al., “Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6,” PLoS One, vol. 6, no. 12, Article ID e28680, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Cerrato, P. Brazis, M. F. della Valle, A. Miolo, and A. Puigdemont, “Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFα release from canine skin mast cells,” Veterinary Immunology and Immunopathology, vol. 133, no. 1, pp. 9–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. R. di Paola, D. Impellizzeri, A. Torre et al., “Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice,” Journal of Leukocyte Biology, vol. 91, pp. 911–920, 2012. View at Publisher · View at Google Scholar
  44. R. di Paola, D. Impellizzeri, P. Mondello et al., “Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice,” Shock, vol. 38, pp. 356–366, 2012. View at Publisher · View at Google Scholar
  45. J. M. K. Hesselink, “New targets in pain, non-neuronal cells, and the role of palmitoylethanolamide,” Open Pain Journal, vol. 5, no. 1, pp. 12–23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. J. M. Keppel Hesselink and T. A. Hekker, “Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series,” Journal of Pain Research, vol. 5, pp. 437–442, 2012. View at Google Scholar